Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancer

✍ Scribed by Kohei Shitara; Takashi Ura; Keitaro Matsuo; Daisuke Takahari; Tomoya Yokota; Satoshi Yuki; Motoki Yoshida; Setsuo Utsunomiya; Yozo Sato; Hidekazu Yamaura; Mina Kato; Yoshitaka Inaba; Masahiro Tajika; Hiroki Kawai; Kentaro Yamazaki; Yoshito Komatsu; Kei Muro

• Book ID: 116430778
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 228 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2011.05.015